Sjögren’s Syndrome Treatments in the Microbiome Era is a research paper published in Advances in Geriatric Medicine and Research (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDCR NIH HHS
Grant: R43 DE026379
NIDCR NIH HHS
Grant: R44 DE026379
NIDCR NIH HHS
Grant: R01 DE026450
NIDCR NIH HHS
Grant: R56 DE026450
NIDCR NIH HHS
Grant: SB1 DE030833
National Institutes of Health
Grant: 5SB1DE030833-03
A Novel Probiotic for the Treatment of Sjogren's Syndrome
National Institutes of Health
Grant: 1R43DE026379-01
A Novel Probiotic for the Treatment of Sjogren's Syndrome
National Institutes of Health
Grant: 5R01DE026450-05
Regulatory Cell Therapy for Sjögren's Syndrome.
FWCI
0.71
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals